Noticias de investigación

Joan Montero and colleagues in Boston suggest a new strategy for melanoma patients

IBEC researcher Joan Montero authors a paper in Nature Communications which uncovers a key adaptation that melanoma cancer cells use to evade current therapies. This finding might allow physicians to use better drug combinations to improve patient outcomes in the future.

Despite significant advances in cancer diagnosis and treatment, most targeted cancer therapies fail to achieve complete tumor regressions or durable remission. Understanding why these treatments are not always efficient has remained a main challenge for researchers and physicians. Now, Joan Montero from the IBEC and colleagues at Dana-Farber Cancer Institute/Harvard Medical School in USA report in Nature Communications a mechanism that uncovers why some therapies fail to treat melanoma.

Read more…

Noticias IBEC

El Congreso de la Sociedad Española de Ingeniería Biomédica reúne más de 200 investigadores bajo el lema “Hacia una Salud Personalizada y Universal”

Raimon Jané, Presidente de la Sociedad Española de Ingeniería Biomédica (SEIB) y Jefe de Grupo en el Instituto de Bioingeniería de Cataluña (IBEC) y en CIBER-BBN, inauguró el congreso junto al Consejero de Sanidad del Gobierno de Cantabria, el Rector de la Universidad de Cantabria, el Gerente del Hospital y el Presidente del Comité Organizador del CASEIB2019.

Read more…